Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELOSULFASE ALFA vs ELRANATAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELOSULFASE ALFA vs ELRANATAMAB: Safety Overview

Metric ELOSULFASE ALFA ELRANATAMAB
Total FAERS Reports 5,024 758
Deaths Reported 118 177
Death Rate 2.3% 23.4%
Hospitalizations 1,056 482
Average Patient Age 17.4 yrs 67.6 yrs
% Female Patients 56.7% 45.2%
Manufacturer BioMarin Pharmaceutical Inc. Pfizer Laboratories Div Pfizer Inc
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription Prescription